Both, the mandatory rebates (regardless of the exact percentage) as well as the Preismoratorium, constitute a ‘price freeze’ in the meaning of Article 4(1) of Directive 89/105 [Council Directive 89/105/EEC of 21 December 1988 relating to the transparency of measures regulating the prices of medicinal products for human use and their inclusion in the scope of national health insurance systems (OJ L 40, 11.2.1989, p. 8).]. Article 4(2) of that Directive lays down that in exceptional circumstances any holder of a marketing authorisation for medical products has the right to apply for a derogation from such a price freeze if justified by ‘particular reasons’. According to the Court of Justice, Member States are, on the basis of this Article, obliged to provide, in all cases, a possibility to apply for such a derogation [Joined Cases C-352/07 to C-356/07, C-365/07 to C-367/07 and C-400/07 A. Menarini and Others [2009] EU:C:2009:217, para. 58.]. German law foresees that pharmaceutical undertakings can apply for an exemption [Exemptions either being a full exemption from the mandatory rebate or a reduction of the rebate. The latter means that, for the period between August 2010 and December 2013, during which the mandatory rebate was 16 %, the BAFA could grant a reduction of 10 % points of the rebate, after which the affected companies were obliged to only grant a 6 % rebate instead of the full 16 %.] from the mandatory rebate and that a federal authority, the Federal Office of Economics and Export Control (Bundesamt für Wirtschaft und Ausfuhrkontrolle, hereinafter ‘BAFA’), decides whether to grant this exemption on a case-by-case basis.
19 3. DESCRIPTION OF THE MEASURE › 3.2. Exemption from the manufacturer's rebate on pharmaceutical products under German law, Decision_act (EU) 2015/1300
In forcesince 27 Mar 2015
Judgment of the Court (Fourth Chamber) of 2 April 2009. A. Menarini Industrie Farmaceutiche Riunite Srl and Others v Ministero della Salute Decision
2 Apr 2009 · 62007CJ0352
- case:eu=C-353/07
- case:eu=C-354/07
- case:eu=C-355/07
- case:eu=C-366/07